LEADER 01699oam  2200529zu 450 
001 9910140015303321
005 20210908061907.0
010   $a3-527-62660-3
035   $a(CKB)1000000000820643
035   $a(SSID)ssj0000354648
035   $a(PQKBManifestationID)11259190
035   $a(PQKBTitleCode)TC0000354648
035   $a(PQKBWorkID)10315913
035   $a(PQKB)10807519
035   $a(PPN)15252553X
035   $a(EXLCZ)991000000000820643
100   $a20160829d2009      uy              
101 0 $aeng
181   $ctxt
182   $cc
183   $acr
200 00$aPost-translational modification of protein biopharmaceuticals
210 31$a[Place of publication not identified]$cWiley VCH$d2009
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a3-527-32074-1 
606   $aProtein Processing, Post-Translational
606   $aGlycosylation
606   $aProtein Engineering$xmethods
606   $aProteins$xanalysis
606   $aBiopharmaceutics
606   $aBiotechnology$xmethods
606   $aPharmacy, Therapeutics, & Pharmacology$2HILCC
606   $aHealth & Biological Sciences$2HILCC
615 12$aProtein Processing, Post-Translational.
615 12$aGlycosylation.
615 22$aProtein Engineering$xmethods.
615 22$aProteins$xanalysis.
615 22$aBiopharmaceutics.
615 22$aBiotechnology$xmethods.
615  7$aPharmacy, Therapeutics, & Pharmacology
615  7$aHealth & Biological Sciences
702   $aWalsh$b Gary
801  0$bPQKB
906   $aBOOK
912   $a9910140015303321
996   $aPost-translational modification of protein biopharmaceuticals$91931709
997   $aUNINA